KRAS and adenoma: In contrast, traditional serrated adenomas usually display low methylation, a stable microsatellite profile (MSS), may exhibit mutations in KRAS or BRAF, but are mostly characterized by their high level of TGFβ pathway activation (Nguyen et al., 2020; Kim and Bodmer, 2022) (Figure 1).